Market Insights: Alignment Healthcare Inc (ALHC)’s Notable Gain of 1.12, Closing at 10.84

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

As of close of business last night, Alignment Healthcare Inc’s stock clocked out at $10.84, up 1.12% from its previous closing price of $10.72. In other words, the price has increased by $1.12 from its previous closing price. On the day, 0.67 million shares were traded. ALHC stock price reached its highest trading level at $11.0 during the session, while it also had its lowest trading level at $10.67.

Ratios:

To gain a deeper understanding of ALHC’s stock, we examine its different ratios. In the meantime, Its Debt-to-Equity ratio is 1.92 whereas as Long-Term Debt/Eq ratio is at 1.91.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stephens on December 03, 2024, Upgraded its rating to Overweight and sets its target price to $17 from $13 previously.

BofA Securities Upgraded its Neutral to Buy on May 30, 2024, whereas the target price for the stock was revised from $7.75 to $11.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 16 ’24 when Maroney Dawn Christine sold 30,000 shares for $11.33 per share. The transaction valued at 340,008 led to the insider holds 1,636,097 shares of the business.

DAWN CHRISTINE MARONEY bought 90,000 shares of ALHC for $1,030,500 on Dec 16 ’24. On Dec 11 ’24, another insider, KAO JOHN E, who serves as the Chief Executive Officer of the company, sold 90,000 shares for $11.65 each. As a result, the insider received 1,048,689 and left with 2,363,100 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 2077984640 and an Enterprise Value of 1874186496. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.84 while its Price-to-Book (P/B) ratio in mrq is 18.13. Its current Enterprise Value per Revenue stands at 0.759 whereas that against EBITDA is -20.006.

Stock Price History:

Over the past 52 weeks, ALHC has reached a high of $14.25, while it has fallen to a 52-week low of $4.46. The 50-Day Moving Average of the stock is -8.60%, while the 200-Day Moving Average is calculated to be 21.17%.

Shares Statistics:

It appears that ALHC traded 1.86M shares on average per day over the past three months and 1546050 shares per day over the past ten days. A total of 191.60M shares are outstanding, with a floating share count of 92.15M. Insiders hold about 51.93% of the company’s shares, while institutions hold 42.63% stake in the company. Shares short for ALHC as of 1732838400 were 11110055 with a Short Ratio of 5.02, compared to 1730332800 on 4508811. Therefore, it implies a Short% of Shares Outstanding of 11110055 and a Short% of Float of 9.0500005.

Most Popular